IVIM Technology Q1 2026 Sales Plummet, Operating Loss Continues... Order Backlog of KRW 1.77 Billion Secured

Q1 2026 revenue of KRW 76.8 million (down 49% from KRW 150.2 million in Q1 2025)
Operating loss of approximately KRW 1.36 billion (similar to prior year quarter)
Net loss of KRW 1.36 billion, basic loss per share of KRW 90
Order backlog of KRW 1.77 billion (3 intravital microscopes and CRO services) scheduled for delivery in 2026
Cash and cash equivalents of KRW 6.13 billion, plus short-term financial products of KRW 8.40 billion, totaling KRW 14.53 billion
2025 actual revenue fell 77.9% short of securities registration statement forecast; operating loss exceeded forecast by 325%
Credit rating: BB0 (Seoul Credit Rating Information)
R&D expenses of KRW 74.3 million, representing 96.8% of revenue (due to low revenue base)
No share buyback, cancellation, or dividend plans
Under management item designation grace period (applying technology growth company special exemption)